Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
The majority of prostate cancers (PCa) express high levels of androgen receptor (AR) and
are dependent for their growth on testosterone produced by the testes, which is reduced in …
are dependent for their growth on testosterone produced by the testes, which is reduced in …
Cancer chemoprevention.
SM Lippman, SE Benner, WK Hong - Journal of Clinical Oncology, 1994 - ascopubs.org
PURPOSE To review the most important recent advances in clinical trials and biologic
studies within the growing field of chemoprevention. METHODS The most critical methods …
studies within the growing field of chemoprevention. METHODS The most critical methods …
[PDF][PDF] The molecular taxonomy of primary prostate cancer
There is substantial heterogeneity among primary prostate cancers, evident in the spectrum
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …
of molecular abnormalities and its variable clinical course. As part of The Cancer Genome …
Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer
CJ Logothetis, GE Gallick, SN Maity, J Kim, A Aparicio… - Cancer discovery, 2013 - AACR
Recently, many therapeutic agents for prostate cancer have been approved that target the
androgen receptor and/or the prostate tumor microenvironment. Each of these therapies has …
androgen receptor and/or the prostate tumor microenvironment. Each of these therapies has …
Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer
JL Mohler, MA Titus, S Bai, BJ Kennerley, FB Lih… - Cancer research, 2011 - AACR
The androgen receptor (AR) mediates the growth of benign and malignant prostate in
response to dihydrotestosterone (DHT). In patients undergoing androgen deprivation …
response to dihydrotestosterone (DHT). In patients undergoing androgen deprivation …
Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice
F Zhao, HL Franco, KF Rodriguez, PR Brown, MJ Tsai… - Science, 2017 - science.org
The sexual differentiation paradigm contends that the female pattern of the reproductive
system is established by default because the male reproductive tracts (Wolffian ducts) in the …
system is established by default because the male reproductive tracts (Wolffian ducts) in the …
[HTML][HTML] The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells
B Hawthorne, K Lund, S Freggiaro, R Kaga… - Biomedicine & …, 2022 - Elsevier
Abstract Introduction Panax notoginseng (Burkill) FH commonly referred to as Sanqi, is a
Chinese herb that has long been used to treat various conditions including blood disorders …
Chinese herb that has long been used to treat various conditions including blood disorders …
[HTML][HTML] Drug repurposing approach, potential drugs, and novel drug targets for COVID-19 treatment
ZD Kifle, AG Ayele, EF Enyew - Journal of Environmental and Public …, 2021 - hindawi.com
Novel coronavirus first appeared in Wuhan, China, in December 2019, and it speedily
expanded globally. Some medications which are used to treat other diseases seem to be …
expanded globally. Some medications which are used to treat other diseases seem to be …
Repurposing existing drugs for COVID-19: an endocrinology perspective
FA Cadegiani - BMC endocrine disorders, 2020 - Springer
Abstract Background Coronavirus Disease 2019 (COVID-19) is a multi-systemic infection
caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that …
caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that …
Targeted androgen pathway suppression in localized prostate cancer: a pilot study
EA Mostaghel, PS Nelson, P Lange, DW Lin… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Ligand-mediated activation of the androgen receptor (AR) is critical for prostate
cancer (PCa) survival and proliferation. The failure to completely ablate tissue androgens …
cancer (PCa) survival and proliferation. The failure to completely ablate tissue androgens …